secwatch / observer
8-K filed March 20, 2023, 7:59 PM ET CIK 0001159281
M&A confidence high sentiment neutral materiality 1.00

AlerisLife Inc.: M&A transaction — AlerisLife completes $1.31/share take-private merger with ABP; shares delisted

AlerisLife Inc.

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Barbara D. Gilmore

Director
AlerisLife Inc.
Effective
2023-03-20
Filed
March 20, 2023, 7:59 PM ET
Barbara D. Gilmore, Jennifer B. Clark, Gerard M. Martin, Bruce M. Gans, and Donna D. Fraiche resigned as directors of the Company.
Departed

Jennifer B. Clark

Director
AlerisLife Inc.
Effective
2023-03-20
Filed
March 20, 2023, 7:59 PM ET
Barbara D. Gilmore, Jennifer B. Clark, Gerard M. Martin, Bruce M. Gans, and Donna D. Fraiche resigned as directors of the Company.
Departed

Gerard M. Martin

Director
AlerisLife Inc.
Effective
2023-03-20
Filed
March 20, 2023, 7:59 PM ET
Barbara D. Gilmore, Jennifer B. Clark, Gerard M. Martin, Bruce M. Gans, and Donna D. Fraiche resigned as directors of the Company.
Departed

Bruce M. Gans

Director
AlerisLife Inc.
Effective
2023-03-20
Filed
March 20, 2023, 7:59 PM ET
Barbara D. Gilmore, Jennifer B. Clark, Gerard M. Martin, Bruce M. Gans, and Donna D. Fraiche resigned as directors of the Company.
Departed

Donna D. Fraiche

Director
AlerisLife Inc.
Effective
2023-03-20
Filed
March 20, 2023, 7:59 PM ET
Barbara D. Gilmore, Jennifer B. Clark, Gerard M. Martin, Bruce M. Gans, and Donna D. Fraiche resigned as directors of the Company.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Barbara D. Gilmore resigned as Director at AlerisLife Inc..

Action
resigned
Role
Director
Exact text from the filing
Barbara D. Gilmore, Jennifer B. Clark, Gerard M. Martin, Bruce M. Gans, and Donna D. Fraiche resigned as directors of the Company.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Jennifer B. Clark resigned as Director at AlerisLife Inc..

Action
resigned
Role
Director
Exact text from the filing
Barbara D. Gilmore, Jennifer B. Clark, Gerard M. Martin, Bruce M. Gans, and Donna D. Fraiche resigned as directors of the Company.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Gerard M. Martin resigned as Director at AlerisLife Inc..

Action
resigned
Role
Director
Exact text from the filing
Barbara D. Gilmore, Jennifer B. Clark, Gerard M. Martin, Bruce M. Gans, and Donna D. Fraiche resigned as directors of the Company.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Bruce M. Gans resigned as Director at AlerisLife Inc..

Action
resigned
Role
Director
Exact text from the filing
Barbara D. Gilmore, Jennifer B. Clark, Gerard M. Martin, Bruce M. Gans, and Donna D. Fraiche resigned as directors of the Company.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Donna D. Fraiche resigned as Director at AlerisLife Inc..

Action
resigned
Role
Director
Exact text from the filing
Barbara D. Gilmore, Jennifer B. Clark, Gerard M. Martin, Bruce M. Gans, and Donna D. Fraiche resigned as directors of the Company.
View on SEC.gov
Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

AlerisLife Inc.: Amended and restated articles of incorporation in their entirety.

Change
charter amendment
Exact text from the filing
Pursuant to the terms of the Merger Agreement, as of the Effective Time, the Company’s amended and restated articles of incorporation were amended and restated in their entirety (the “Amended Articles of Incorporation”), and the Company’s amended and restated bylaws were amended and restated in their entirety (the “Amended Bylaws”).
View on SEC.gov
Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

AlerisLife Inc.: Amended and restated bylaws in their entirety.

Change
bylaw amendment
Exact text from the filing
Pursuant to the terms of the Merger Agreement, as of the Effective Time, the Company’s amended and restated articles of incorporation were amended and restated in their entirety (the “Amended Articles of Incorporation”), and the Company’s amended and restated bylaws were amended and restated in their entirety (the “Amended Bylaws”).
View on SEC.gov
M&A Transactions SEC 8-K Item 2.01/5.01 confidence 0.9

AlerisLife Inc. underwent a change of control involving ABP for $1.31 per Share in cash (closed 2023-03-20).

Action
change of control
Counterparty
ABP
Consideration
$1.31 per Share in cash
Closing
2023-03-20
Exact text from the filing
any other direct or indirect wholly owned subsidiary of ABP or any person that owns, directly or indirectly, all of the outstanding equity interests of Purchaser) at a price of $1.31 per Share, net to the seller in cash, without interest, and subject to any applicable withholding of taxes (the “Offer Price”). At one minute after 11:59 p.m., Eastern Time, on
View on SEC.gov
Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

AlerisLife Inc. entered into Agreement and Plan of Merger with ABP Acquisition 2 LLC (effective 2023-02-02).

Action
entry
Agreement
merger
Counterparty
ABP Acquisition 2 LLC
Effective
2023-02-02
Exact text from the filing
the Company entered into an Agreement and Plan of Merger (the “Merger Agreement”) with ABP Acquisition 2 LLC (“Purchaser”), a Maryland limited liability company and a wholly-owned subsidiary of ABP Acquisition LLC (“ABP”).
View on SEC.gov

Browse all governance changes →

Source: SEC EDGAR
accession 0001104659-23-034255
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.